SCHEMBL18157735

SCHEMBL18157735

Cc1ccc(/C=C/c2[nH]c3ccccc3c2/C=C/c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.50
RAB9A P51151 9/20 0.50
MAPT P10636 8/20 0.50
MEN1 O00255 8/20 0.50
KMT2A Q03164 8/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2D6 P10635 2/20 0.50
HTT P42858 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
ALPG P10696 1/20 0.50
KDM4E B2RXH2 4/20 0.49
GLA P06280 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GAA P10253 2/20 0.49
POLB P06746 1/20 0.49
TP53 P04637 1/20 0.46
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18160186 1.00 NPC1 (0.50) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18160143 0.97 MAPT (0.52) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18157755 0.91 NPC1 (0.50) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL28555372 0.91 NPC1 (0.50) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18160288 0.90 KIF11 (0.45) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18157734 0.90 MAPT (0.47) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18157750 0.90 NFE2L2 (0.53) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18160287 0.90 NFE2L2 (0.53) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18157738 0.90 MAPT (0.47) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL18157754 0.88 RELA (0.55) NPC1RAB9AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD NPC1 1892/4885RAB9A 679/4885MAPT 2538/4885
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD NPC1 1892/4885RAB9A 679/4885MAPT 2538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.